GLP1R and liver dysplastic nodule: In addition to the traditional treatment methods such as antioxidant treatment and the improvement of microcirculatory activity, treatment strategies utilizing SGLT-2 inhibitors, GLP-1R agonists, and ACEI/ARB drugs are also emerging as promising approaches to the treatment of DN [31].